↓ Skip to main content

Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation

Overview of attention for article published in Molecular Cancer, November 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog

Citations

dimensions_citation
113 Dimensions

Readers on

mendeley
141 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation
Published in
Molecular Cancer, November 2010
DOI 10.1186/1476-4598-9-305
Pubmed ID
Authors

Giovanni L Gravina, Claudio Festuccia, Francesco Marampon, Vladimir M Popov, Richard G Pestell, Bianca M Zani, Vincenzo Tombolini

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 141 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 <1%
Indonesia 1 <1%
Ireland 1 <1%
United Kingdom 1 <1%
Spain 1 <1%
Unknown 136 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 30 21%
Researcher 26 18%
Student > Bachelor 16 11%
Student > Master 16 11%
Other 10 7%
Other 29 21%
Unknown 14 10%
Readers by discipline Count As %
Agricultural and Biological Sciences 40 28%
Biochemistry, Genetics and Molecular Biology 27 19%
Medicine and Dentistry 26 18%
Chemistry 13 9%
Neuroscience 4 3%
Other 13 9%
Unknown 18 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 November 2021.
All research outputs
#2,787,224
of 25,374,917 outputs
Outputs from Molecular Cancer
#171
of 1,918 outputs
Outputs of similar age
#15,535
of 190,188 outputs
Outputs of similar age from Molecular Cancer
#4
of 16 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,918 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 190,188 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.